echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Cell sub-issue: Protein profiles of 949 cancer cell lines across over 40 cancer types released

    Cell sub-issue: Protein profiles of 949 cancer cell lines across over 40 cancer types released

    • Last Update: 2022-08-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Introduction: Proteome research is a science that studies the composition and activity of proteins in cells, tissues and even the whole life at the overall level, so as to obtain an overall and comprehensive understanding of disease occurrence, cell metabolism and other processes at the protein leve.


    On August 8, "Cancer Cell" published a pan-cancer proteomic map of 949 human cancer cell lines in more than 40 cancer types through a study "Pan-cancer proteomic map of 949 human cell lines", and found that there are 8498 proteins have extensive post-transcriptional regulation phenomena, and drug response-related biomarkers were discovered based on deep learnin.


    Doi: 11016/.


    Research Background

    01

    Direct measurements of proteins can provide insights into the dynamic molecular behavior of cells and can deepen our understanding of genotype-phenotype relationships, however, the complexity and genomics of cancer cannot accurately predict the proteom.


    Cell lines are important models for understanding cellular processes and oncogene drive signatures, however, proteomics of cancer cell lines is largely inaccessible due to the scope of cancer types or the number of sample.


    research process

    02

    Proteomic testing of 949 cancer cell lines: To construct a pan-cancer proteomic map, the researchers analyzed data from 28 tissues and more than 40 different genetic and Histology of 949 human cancer cell lines for protein detection followed by quantification Collecting complete proteomic data, high correlations were observed between replicates for each cell line and cells were found to be enriched compared to other proteins Types of proteins have a higher correlation between the transcriptome and the proteom.


    FigurePan-cancer proteomic profiles of 949 human cancer cell lines

    Specific proteome changes in cancer cells: To explore which driving factors play an important role in tumor biological behavior, the researchers conducted multi-omics factor analysis and found that the classic markers of epithelial-mesenchymal transition (EMT) vimentin and E -Cadherin was significantly overexpressed in various cancers, and the score of EMT gene set enrichment analysis was also significantly upregulate.


    FigurePost-transcriptional regulation in different cancer cell types

    Cancer cell-specific markers: In order to further develop biomarkers that can predict drug response through proteomics, the researchers determined the sensitivity of 189 drugs by combining proteomics with detection of drug sensitivit.


    FigureProtein Biomarkers

    Significance

    03

    This study publishes a large pan-cancer proteome map that provides extensive protein-level cancer data beyond existing omics data - quantifying 949 human cancers representing 28 tissues and more than 40 histologically distinct cancer types 8,498 proteins and broad genotypes in cell line.


    References:

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.